Torrent Pharmaceuticals (Large Cap - Potential Multibagger) Share Target 2025, 2026 To 2035
|
Torrent Pharmaceuticals Limited |
|||
|
Price: ₹3,039.35 (-1.83%) | ||
| 52 Week Low: ₹2,487.80 52 Week High: ₹3,590.70 |
|||
| Market Capital: 91,139.86 Crore (Largecap) | |||
| Healthcare -> Drug Manufacturers—Specialty & Generic | |||
Show Table of Contents
Table of Contents
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: Torrent Pharmaceuticals Share Price Target For 2025
- 1.1.1: Torrent Pharmaceuticals Share Price Target Table For 2025
- 1.1.2: Short-Term Technical Outlook
- 1.2: Torrent Pharmaceuticals Share Price Target For 2026
- 1.2.1: Torrent Pharmaceuticals Share Price Target Table For 2026
- 1.2.2: Long-Term Technical Outlook
- 2: Approach 2: Machine Learning By Studying Historical Prices
- 2.1: Torrent Pharmaceuticals Share Price Target Chart and Table From 2025, 2026, 2027 to 2035
- 3: Torrent Pharmaceuticals Brief Company Overview
- 4: Torrent Pharmaceuticals Financial Performance
- 4.0.1: Is Torrent Pharmaceuticals A Good Buy For Long Term?
Torrent Pharmaceuticals, a Large Cap company in the Drug Manufacturers—Specialty & Generic Industry has delivered 200.2% returns in 5-year showing 9.7% quarterly revenue growth with 14.3% profit margin, making it a potential Multibagger.
To predict the Torrent Pharmaceuticals's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Torrent Pharmaceuticals Share Price Target For 2025
The line chart displays the monthly closing prices of Torrent Pharmaceuticals with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Torrent Pharmaceuticals shares in 2025, see the table below.
Torrent Pharmaceuticals Share Price Target Table For 2025
| Level | Value | Analysis |
|---|---|---|
| 2025 Target 3 | 3269.8 (+7.58%) | Price Action: 15 Jan 2025 High |
| 2025 Target 2 | 3235.85 (+6.46%) | Price Action: 11 Feb 2025 High |
| 2025 Target 1 | 3201.25 (+5.32%) | Price Action: 17 Jan 2025 High |
| Current Price | 3039.35 | Torrent Pharmaceuticals's share price as of 21 Feb 2025 |
| Stop Loss 1 | 2966.05 (-2.42%) | Price Action: 14 Feb 2025 Low |
| Stop Loss 2 | 2935.1 (-3.44%) | Price Action: 19 Jul 2024 Low |
| Stop Loss 3 | 2904.75 (-4.43%) | Price Action: 21 Jun 2024 High |
Short-Term Technical Outlook
Current Technical Position: Torrent Pharmaceuticals is displaying bearish momentum trading below key moving averages.
Key Technical Level: The 25-day moving average at ₹3170.78 serves as the nearest technical reference point.
Historical Returns: 3-month: -8.57% | 6-month: -12.79% | 1-year: +14.24%
Torrent Pharmaceuticals Share Price Target For 2026
The line chart displays the monthly closing prices of Torrent Pharmaceuticals with a black line. The green line shows three potential target prices for 2026, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Torrent Pharmaceuticals shares in 2026, see the table below.
Torrent Pharmaceuticals Share Price Target Table For 2026
| Level | Value | Analysis |
|---|---|---|
| 2026 Target 3 | 4474.38 (+47.21%) | Price Action: Chart |
| 2026 Target 2 | 4390.95 (+44.47%) | Price Action: Chart |
| 2026 Target 1 | 4347.48 (+43.03%) | Fibonacci Extension Level 64.90% |
| Current Price | 3039.35 | Torrent Pharmaceuticals's share price as of 21 Feb 2025 |
| Stop Loss 1 | 2739.59 (-9.86%) | Price Action: 06 Jun 2024 Low |
| Stop Loss 2 | 2706.41 (-10.96%) | Price Action: 30 Apr 2024 High |
| Stop Loss 3 | 2679.31 (-11.85%) | Price Action: 02 Apr 2024 High |
Long-Term Technical Outlook
52-Week Range Analysis: Torrent Pharmaceuticals is currently trading at 50.0% of its 52-week range (₹2487.8 - ₹3590.7).
Long-Term Trend Analysis: The stock is in a bearish long-term trend, trading below key long-term moving averages.
Long-Term Performance: 1-year: +14.24% | 3-year: +127.6% | 5-year: +200.19%
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Torrent Pharmaceuticals Share Price Target Chart and Table From 2025, 2026, 2027 to 2035
| Year | Target 1 | Target 1 YoY Chg % | Target 2 |
|---|---|---|---|
| Current Price | ₹3,039.35 | ||
| 2025 | ₹4,614.92 | +51.83% | ₹4,684.14 |
| 2026 | ₹5,526.47 | +19.75% | ₹5,609.37 |
| 2027 | ₹7,498.21 | +35.67% | ₹7,610.68 |
| 2028 | ₹9,387.50 | +25.19% | ₹9,528.31 |
| 2029 | ₹11,706.07 | +24.69% | ₹11,881.66 |
| 2030 | ₹14,439.49 | +23.35% | ₹14,656.08 |
| 2031 | ₹17,813.05 | +23.36% | ₹18,080.25 |
| 2032 | ₹20,244.15 | +13.64% | ₹20,547.81 |
| 2033 | ₹23,812.00 | +17.62% | ₹24,169.18 |
| 2034 | ₹29,684.21 | +24.66% | ₹30,129.47 |
| 2035 | ₹35,668.11 | +20.15% | ₹36,203.13 |
Note: Target 1 and Target 2 represent price levels that the stock is most likely to achieve during the respective year, based on machine learning algorithms analyzing historical price patterns and market behavior. These predictions are generated through comprehensive analysis of the stock's historical data using advanced ML models.
Torrent Pharmaceuticals Brief Company Overview
Torrent Pharmaceuticals Limited: Crafting Healthcare Solutions Worldwide Torrent Pharmaceuticals Limited, a renowned pharmaceutical company, has been a pioneer in the industry for over six decades. Headquartered in Ahmedabad, India, Torrent has a global presence spanning the...
United States, Brazil, Germany, and many other countries. Key Products and Services Generic pharmaceutical formulations Contract manufacturing services Diverse Product Range Cardiovascular Central nervous system Gastro-intestinal Women healthcare Diabetology Pain management Gynecology Oncology Anti-infective Vitamins, minerals, and nutrients Commitment to Innovation Torrent Pharmaceuticals Limited is committed to delivering affordable healthcare solutions while adhering to the highest quality standards. The company's dedication to innovation and research has earned it a reputation as a leader in the pharmaceutical industry.Torrent Pharmaceuticals Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 91,139.86 Crore | Market valuation of Torrent Pharmaceuticals's shares. |
| Revenue (TTM) | 10,474.15 Crore | Total revenue generated by Torrent Pharmaceuticals over the past twelve months. |
| Net Income (TTM) | +1,494.23 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | +24.01% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | +14.26% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) |
+9.69% | Change in revenue compared to the previous quarter. |
| Earnings Growth (YOY Quarterly) |
+56.49% | Change in earnings compared to the same quarter last year. |
| Debt-to-Equity (D/E) Ratio |
66.93 | Company's total debt divided by total shareholder equity. |
| Total Debt | 4,489 Crore | Sum of Torrent Pharmaceuticals's current & long-term financial obligations. |
| Total Cash | 790 Crore | Total amount of liquid funds available to Torrent Pharmaceuticals. |
| Beta | 0.29 | Beta is less than 1 indicating that the Torrent Pharmaceuticals's price is less volatile than the market. |
Is Torrent Pharmaceuticals A Good Buy For Long Term?
Torrent Pharmaceuticals, a large-cap stock with strong financials, shows promising growth potential for long-term investors. Its revenue and earnings have grown significantly, and its profit margin remains healthy. While it carries some debt, its cash balance offers financial stability. The stock's past performance indicates a consistent upward trend, making it an attractive buy for long-term portfolio growth.
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
